Who founded Carenostics?

Carenostics was founded by Bharat Rao in 2022.

Who are Carenostics's investors?

Carenostics's investors include Gaingels, GreatPoint Ventures, M13.

How much funding has Carenostics raised?

Carenostics has disclosed $4.7M raised across 1 round.

Where is Carenostics headquartered?

Carenostics is headquartered in Berwyn, US.

Carenostics

Berwyn, US · Founded 2022 · Delaware corporation · 3 known investors

Find your way into Carenostics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Carenostics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Carenostics builds an AI assistant purpose-built for organ transplant care, covering the full patient journey from referral, evaluation, and listing through waitlist maintenance and post-transplant monitoring. Its software is designed for transplant teams — coordinators, administrators, and surgeons — at transplant centers in the United States.

AI & Machine Learning Digital Health Healthtech

Founders & leadership

Carenostics was founded in 2022 by Bharat Rao.

Bharat Rao Founder · President & Chief AI OfficerDr. Bharat Rao has spent over two decades developing and deploying AI systems in healthcare, including leading the Computer-Aided Diagnosis group at Siemens Healthcare where he guided FDA approval of LungCAD for lung cancer detection, and founding KPMG's Healthcare & Life Sciences AI practice before co-founding Carenostics. He holds 63 patents and has authored over 150 peer-reviewed publications.

Kanishka RaoCo-Founder & Chief Executive Officer30 Under 30 2025

Investors · 3

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: funding news · prweb.com · gaingels.com · Not right? Tell us

GreatPoint Ventureslisted by GreatPoint VenturesSan Francisco · $250K – $20M

How we know: GreatPoint Ventures's portfolio page · funding news · prweb.com · the VCSheet dataset · Not right? Tell us

M13listed by M13New York · $4M – $7M

How we know: M13's portfolio page · a partner's Signal profile · funding news · prweb.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$4.7M disclosed across 1 round · 2023

▶$4.7MraisedSep 2023 · 4 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Kanishka RaoExecutive Officer, Director
Bharat RaoExecutive Officer, Director

Offering amount: $4.7M
Amount sold: $4.7M
First sale: Sep 2023
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

Elion

RegardRegard builds healthcare technology that makes patient medical records fully accessible to clinicians at the point of care, enabling more informed diagnosis and documentation. The company serves physicians and healthcare systems seeking to improve clinical decision-making and patient outcomes.

CaregenticCaregentic provides an episode operations layer for hospital TEAM (Transitional Care Management) programs, automating 30-day post-discharge patient monitoring, care coordination, and EHR documentation to reduce readmissions and penalties under CMS's bundled payment model.

Quadrant HealthQuadrant Health uses electronic health record and messaging data to forecast patient disease progression and enable early intervention.

CaresyntaxDigital health platform using AI to analyze video, audio, image and device data in the operating room to improve surgical outcomes and patient safety.

NosticsNostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.

Companies working in the same space as Carenostics.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Science Foundation	Phase I	2022	$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Carenostics 9/15/2023 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com · Sep 2023

Carenostics Raises $5M in Seed Fundingfinsmes.com · Sep 2023

Frequently asked questions

What does Carenostics do?: Carenostics builds an AI assistant purpose-built for organ transplant care, covering the full patient journey from referral, evaluation, and listing through waitlist maintenance and post-transplant monitoring. Its software is designed for transplant teams — coordinators, administrators, and surgeons — at transplant centers in the United States.
Who founded Carenostics?: Carenostics was founded by Bharat Rao in 2022.
Who are Carenostics's investors?: Carenostics's investors include Gaingels, GreatPoint Ventures, M13.
How much funding has Carenostics raised?: Carenostics has disclosed $4.7M raised across 1 round.
Where is Carenostics headquartered?: Carenostics is headquartered in Berwyn, US.